News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
675,901 Results
Type
Article (51263)
Company Profile (436)
Press Release (624202)
Multimedia
Podcasts (107)
Webinars (13)
Section
Business (182378)
Career Advice (3117)
Deals (33559)
Drug Delivery (113)
Drug Development (81096)
Employer Resources (182)
FDA (15948)
Job Trends (14259)
News (319746)
Policy (30722)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (9)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (9)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (10)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2853)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (88)
Alliances (47855)
ALS (96)
Alzheimer's disease (1460)
Antibody-drug conjugate (ADC) (152)
Approvals (15920)
Artificial intelligence (281)
Autoimmune disease (27)
Automation (15)
Bankruptcy (309)
Best Places to Work (11532)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (319)
Bladder cancer (83)
Brain cancer (29)
Breast cancer (289)
Cancer (2323)
Cardiovascular disease (190)
Career advice (2631)
Career pathing (34)
CAR-T (167)
Cell therapy (470)
Cervical cancer (20)
Clinical research (65673)
Collaboration (880)
Compensation (508)
Complete response letters (27)
COVID-19 (2720)
CRISPR (45)
C-suite (252)
Cystic fibrosis (106)
Data (2162)
Decentralized trials (2)
Denatured (38)
Depression (51)
Diabetes (284)
Diagnostics (6277)
Digital health (18)
Diversity (7)
Diversity, equity & inclusion (45)
Drug discovery (130)
Drug pricing (113)
Drug shortages (32)
Duchenne muscular dystrophy (101)
Earnings (68852)
Editorial (43)
Employer branding (23)
Employer resources (159)
Events (114193)
Executive appointments (740)
FDA (17187)
Featured Employer (57)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (781)
Gene editing (113)
Generative AI (25)
Gene therapy (343)
GLP-1 (791)
Government (4533)
Grass and pollen (6)
Guidances (49)
Healthcare (19309)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (135)
Indications (29)
Infectious disease (2868)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (49)
Intellectual property (98)
Interviews (605)
IPO (15895)
IRA (47)
Job creations (3197)
Job search strategy (2157)
Kidney cancer (10)
Labor market (36)
Layoffs (469)
Leadership (22)
Legal (6581)
Liver cancer (71)
Lung cancer (331)
Lymphoma (152)
Machine learning (6)
Management (64)
Manufacturing (324)
MASH (71)
Medical device (13125)
Medtech (13129)
Mergers & acquisitions (18249)
Metabolic disorders (739)
Multiple sclerosis (81)
NASH (22)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (2025)
NextGen: Class of 2025 (6716)
Non-profit (4678)
Northern California (2608)
Now hiring (33)
Obesity (398)
Opinion (267)
Ovarian cancer (75)
Pain (93)
Pancreatic cancer (79)
Parkinson's disease (154)
Partnered (22)
Patents (233)
Patient recruitment (107)
Peanut (49)
People (54700)
Pharmaceutical (91)
Pharmacy benefit managers (21)
Phase I (20459)
Phase II (28993)
Phase III (21801)
Pipeline (1173)
Policy (153)
Postmarket research (2423)
Preclinical (8687)
Press Release (68)
Prostate cancer (108)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (416)
Real estate (5666)
Recruiting (72)
Regulatory (21764)
Reports (38)
Research institute (2529)
Resumes & cover letters (497)
Rett syndrome (4)
RNA editing (4)
RSV (46)
Schizophrenia (76)
Series A (138)
Series B (86)
Service/supplier (12)
Sickle cell disease (58)
Southern California (2259)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (34)
Startups (3477)
State (2)
Stomach cancer (16)
Supply chain (70)
Tariffs (33)
The Weekly (68)
United States (22924)
Vaccines (741)
Venture capitalists (42)
Weight loss (279)
Women's health (34)
Worklife (19)
Date
Today (194)
Last 7 days (761)
Last 30 days (2481)
Last 365 days (33980)
2025 (10429)
2024 (36240)
2023 (40746)
2022 (51874)
2021 (56459)
2020 (54458)
2019 (47281)
2018 (35810)
2017 (33102)
2016 (32672)
2015 (37781)
2014 (29832)
2013 (24520)
2012 (25992)
2011 (26530)
2010 (24044)
Location
Africa (930)
Alabama (54)
Alaska (7)
Arizona (189)
Arkansas (14)
Asia (40394)
Australia (7059)
California (6009)
Canada (1972)
China (539)
Colorado (265)
Connecticut (277)
Delaware (142)
Europe (93416)
Florida (861)
Georgia (211)
Hawaii (1)
Idaho (59)
Illinois (556)
India (27)
Indiana (314)
Iowa (11)
Japan (160)
Kansas (98)
Kentucky (24)
Louisiana (12)
Maine (60)
Maryland (868)
Massachusetts (4671)
Michigan (233)
Minnesota (385)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (23)
Nevada (58)
New Hampshire (68)
New Jersey (1703)
New Mexico (29)
New York (1718)
North Carolina (1023)
North Dakota (7)
Northern California (2608)
Ohio (201)
Oklahoma (15)
Oregon (36)
Pennsylvania (1339)
Puerto Rico (12)
Rhode Island (31)
South America (1237)
South Carolina (21)
Southern California (2259)
Tennessee (89)
Texas (865)
Utah (165)
Virginia (153)
Washington D.C. (60)
Washington State (568)
West Virginia (3)
Wisconsin (51)
675,901 Results for "the iq group global".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Global Hemp Group Announces Private Placement and Corporate Update
March 18, 2025
·
5 min read
Press Releases
Artera Announces 1st Patient Enrolled in PROSTATE-IQ Trial to Reduce Burden of Hormone Therapy in Men with Prostate Cancer Recurrence After Prostatectomy
March 11, 2025
·
3 min read
Press Releases
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
March 19, 2025
·
10 min read
Press Releases
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
February 26, 2025
·
6 min read
FDA
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Baxter International Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite – enables clinicians to utilize a single, integrated system across a variety of patient care settings.
April 1, 2024
·
9 min read
Sponsored
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
Founded in 2007, Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients with rare neurodegenerative diseases
April 24, 2025
·
6 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Business
Children’s Hospital of Philadelphia Researchers Find Some Patients with Aicardi Goutières Syndrome Have Normal IQ
In a landmark study, researchers from Children’s Hospital of Philadelphia found that two separate objective assessment tools and nonverbal measurements of IQ can help assess cognitive function in children with Aicardi Goutières Syndrome, allowing treatment teams to provide appropriate support and interventions.
June 26, 2024
·
5 min read
Press Releases
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
January 10, 2025
·
5 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
1 of 67,591
Next
